Login / Signup

Prophylaxis with low-molecular-weight heparin reduces thrombotic events and allows continuation of asparaginase containing regimens during intensification phase.

Hassan SibaiEshetu G AtenafuJack T Seki
Published in: British journal of haematology (2022)
Keyphrases
  • venous thromboembolism
  • growth factor